Navigation Links
Interest in Environment & Sustainability Prevails in Food Technology Survey
Date:6/2/2010

, which requires food products to be labeled when use of biotechnology substantially changes the food’s nutritional content (such as vitamins or fat) or its composition, or when a potential food safety issue is identified. Only 12 percent oppose, and 24% neither support nor oppose the policy.

Perceptions of Food Biotechnology: About seven in ten Americans (69%) say they have heard or read at least “a little” about biotechnology, steady from previous years. Significantly more consumers believe there are foods produced through biotechnology in the supermarket now (28%) compared with 2008 (23%), although these consumers are still the minority.

The majority of consumers are somewhat or very likely to purchase a variety of produce, such as tomatoes or potatoes, modified by biotechnology to provide more healthful fats like Omega-3s (76%); to avoid trans fat (74%); or to make them taste better/fresher (67%).
Impressions of Plant Biotechnology: About one-third (32%) are somewhat or very favorable toward plant biotechnology, with about two in ten (19%) somewhat or very unfavorable and about three in ten (29%) neither favorable nor unfavorable.

Impressions of Animal Biotechnology: About three in ten (29%) Americans are somewhat or very favorable toward animal biotechnology, while slightly more than one-quarter (27%) are somewhat or very unfavorable, and about one-quarter (24%) are neither favorable nor unfavorable.

Interestingly, the majority of consumers who are either unfavorable or neutral in their views toward animal biotechnology cited “I don’t have enough information” about animal biotechnology (55%) and/or “I don’t understand the benefits of using biotechnology with animals” (39%) as their reason(s) for being unfavorable or neutral.

Perceptions of Nanotechnology: Slightly more than one-third (35%) of Americans have read or heard at least “a little”
'/>"/>

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Page: 1 2 3 4 5

Related biology technology :

1. Moffitt Cancer Center Announces Growing Interest in Recently Launched Prognostic Test for Non-Small Cell Lung Cancer
2. United States Securities and Exchange Commission Declares Effective Registration Statement for NeoStems Acquisition of China Biopharmaceuticals Holdings, Inc. and a Controlling Interest in Leading Chinese Pharmaceutical Company; Meeting of Each Com
3. New and Interesting PROSTVAC(TM) Data Indicate Broad Therapeutic Use in Metastatic Prostate Cancer
4. Elbit Imaging Ltd. Announces Interest Rate for the Next Interest Period for Series B Notes
5. Microparts interest group workshop
6. Baseline Research Indicates High Interest in Centocor-Ortho Biotechs SIMPONI(R)
7. Swine Flu Fears Generate Interest in UV Disinfection Technologies...Again
8. Xspray Expands to Meet Pharmas Interest in its Ground-Breaking Particle Production Technology
9. Managing Conflict of Interest Disclosures Simplified for Healthcare Organizations
10. China Biologic Products Completes Acquisition of 90% Controlling Interest in Chongqing Dalin Biologic Technologies Co., Ltd.
11. deCODE to Utilize Grace Period for Interest Payment on Senior Convertible Notes
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Interest in Environment & Sustainability Prevails in Food Technology Survey
(Date:11/26/2014)... November 25, 2014 Continuing its award-winning ... earned three prestigious MarCom Awards for outstanding creative achievement ... a Platinum MarCom Award, the organization’s top honor, in ... St. Louis held in April of this year. The ... 14,000 attendees. Additionally, Nerium was awarded a Gold MarCom ...
(Date:11/26/2014)... DE (PRWEB) November 26, 2014 ... Heroes recognition reception on December 5, 2014, in San ... meeting. The MPN Heroes event will honor clinicians, caregivers, ... field of myeloproliferative neoplasms (MPNs). , Special guest ... discuss his family's cancer journey at the reception. ...
(Date:11/26/2014)...  Roka Bioscience, Inc. (NASDAQ: ROKA ), a ... the detection of foodborne pathogens, today announced that Paul ... th Annual Healthcare Conference on December 2, 2014 at ... York Palace in New York, NY . ... Company, its operations, strategies and prospects may be discussed. To ...
(Date:11/24/2014)... 2014   First ... Elsevier , a world-leading provider of scientific, ... announce the launch of the latest title in the ... in Food Science . ... a new platform to keep up-to-date with the expanding volume ...
Breaking Biology Technology:Nerium International™ Wins One Platinum, Two Gold MarCom Awards 2CURE Magazine and Incyte to Honor MPN Heroes 2CURE Magazine and Incyte to Honor MPN Heroes 3CURE Magazine and Incyte to Honor MPN Heroes 4Roka Bioscience to Present at the Piper Jaffray Healthcare Conference 2Elsevier Announces Launch of New Journal: Current Opinion in Food Science 2Elsevier Announces Launch of New Journal: Current Opinion in Food Science 3
... and OSLO, March 4 Pharmexa A/S and Affitech ... agreement to merge,the two companies by means of a ... Norwegian company, Affitech AS. The purpose of the merger ... vaccine business,into a company focused on the research and ...
... milestones, - Strong R&D investments, especially in EHT Dx21 and EHT ... Recruitment of 311 samples achieved for EHT Dx21, - ... Expansion of the strategic collaboration with Allergan and extension, ... of a new Management Board, - New positioning of Genomic Services ...
... highlights the importance and challenges of ... America. To move beyond the current crisis, we ... knowledge-intensive jobs, invest in "green" science and engineering ... based industries and workers. , Nanotechnologywhich some scientists ...
Cached Biology Technology:Pharmexa and Affitech to Combine Operations to Create a New Antibody Therapeutics Company 2Pharmexa and Affitech to Combine Operations to Create a New Antibody Therapeutics Company 3ExonHit Therapeutics Invested Strongly in 2008 for Pivotal 2009 Results 2ExonHit Therapeutics Invested Strongly in 2008 for Pivotal 2009 Results 3ExonHit Therapeutics Invested Strongly in 2008 for Pivotal 2009 Results 4ExonHit Therapeutics Invested Strongly in 2008 for Pivotal 2009 Results 5ExonHit Therapeutics Invested Strongly in 2008 for Pivotal 2009 Results 6ExonHit Therapeutics Invested Strongly in 2008 for Pivotal 2009 Results 7ExonHit Therapeutics Invested Strongly in 2008 for Pivotal 2009 Results 8ExonHit Therapeutics Invested Strongly in 2008 for Pivotal 2009 Results 9ExonHit Therapeutics Invested Strongly in 2008 for Pivotal 2009 Results 10ExonHit Therapeutics Invested Strongly in 2008 for Pivotal 2009 Results 11Nanotechnology: Will it drive a new innovation economy for the US? 2Nanotechnology: Will it drive a new innovation economy for the US? 3
(Date:11/21/2014)... Nov. 19, 2014  Earlier this year Donald ... College, and one of the most prolific inventors in ... are transmitted from Smartphones to third party agencies. Spector ... has one of the earliest known patents in this ... in the military, child care, elder care and hospital ...
(Date:11/21/2014)... Nov. 20, 2014   Atmel® Corporation (NASDAQ: ... (MCU) and touch technology solutions, today launched the industry,s ... with the widest V cc range from 1.7V ... and faster I 2 C bus communication speeds, and ... memory making them ideal for consumer, industrial, computer, and ...
(Date:11/18/2014)... The Parenteral Drug Association (PDA) today confirmed that seven officials ... least seven more will participate in the upcoming 2014 PDA ... Washington D.C. , Dec. 2-4. ... the regulatory agencies in the United States ... to help advance the use of metrics in the regulatory ...
Breaking Biology News(10 mins):Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4FDA's Janet Woodcock, EMA's Emer Cooke Headline PDA Quality Metrics Conference 2
... bacteria exist as aggressive pathogens, causing diseases ranging from ... syndrome, others play a less malevolent role and some ... study, Cheryl Nickerson and her group at ASU,s Biodesign ... Van de Wiele and lead author Rosemarie De Weirdt ...
... participation in scientific research has deep roots in the ... has taken off spectacularly from launch pads across the ... communications technology and a sea change in a scientific ... Citizen science, crowd-sourced science, DIY research, volunteer monitoring, ...
... A study comparing whether endothelial colony-forming cells (ECFCs) derived from ... are more proliferative and better for forming new blood vessels ... vasculogenic., The study, carried out by researchers at the Indiana ... Cell Medicine [2(3)] and is freely available on-line ...
Cached Biology News:Beneficial bacteria may help ward off infection 2Beneficial bacteria may help ward off infection 3Beneficial bacteria may help ward off infection 4Beneficial bacteria may help ward off infection 5Inaugural cross-disciplinary Public Participation in Scientific Research conference 2Blood vessel forming potential of stem cells from human placenta and umbilical cord blood 2
IHC detection kit for PCNA in cells and tissues...
... Immunogen: Synthetic peptide derived from the ... protein. Specificity: Reacts with the ... Reactivity: Human Mouse (positive controls: WNT1-transfected ... lysates and mouse Mouse-1 cell lysates). ...
The pYES2 vector is designed for native expression of your protein of interest in S. cerevisiae. It contains the URA3 gene for selection in yeast and 2 origin for high-copy maintenance....
... cAMP - [125I] Direct SPA ... SPA.Includes lysis reagents that eliminate lengthy ... cAMP measurement (optional use).Range: 1.32-84.28 ng/ml ... pmol/ml).Overnight protocol.Store at 2-8 C. Category: ...
Biology Products: